期刊
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
卷 40, 期 3, 页码 537-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2014.04.004
关键词
Lupus nephritis; Kidney biopsy; Systemic lupus erythematosus
类别
资金
- NIDDK NIH HHS [U01 DK096927] Funding Source: Medline
The kidney biopsy is the standard of care for diagnosis of lupus nephritis and remains necessary to ensure accurate diagnosis arid guide treatment. Repeat biopsy should be considered when therapy modifications are necessary, as in cases with incomplete or no response, or when stopping therapy for those in remission. There are several promising biomarkers of kidney disorders; however, these markers need to be validated in a prospective clinical trial before being applied clinically. Molecular analysis may provide the information presently lacking from current evaluation of kidney disorders and may better inform on prognosis and treatment considerations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据